Through Rory for women’s health, Roman for men’s health and Zero for smoking cessation, Ro now treats 20 conditions. The company’s $1.5bn valuation is courtesy of a new $200m investment from existing investors led by General Catalyst.
Join our network of executives who receive the MBS News daily, as well as the insights, analysis and our weekly column in The Weekend Edition.
You’ll be able to unsubscribe at any time.